116 related articles for article (PubMed ID: 28713943)
1. Astragaloside IV downregulates the expression of MDR1 in Bel‑7402/FU human hepatic cancer cells by inhibiting the JNK/c‑Jun/AP‑1 signaling pathway.
Wang PP; Luan JJ; Xu WK; Wang L; Xu DJ; Yang CY; Zhu YH; Wang YQ
Mol Med Rep; 2017 Sep; 16(3):2761-2766. PubMed ID: 28713943
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.
Wang PP; Xu DJ; Huang C; Wang WP; Xu WK
Mol Med Rep; 2014 Jun; 9(6):2131-7. PubMed ID: 24676670
[TBL] [Abstract][Full Text] [Related]
3. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.
Bark H; Choi CH
Cancer Chemother Pharmacol; 2010 May; 65(6):1131-6. PubMed ID: 19763573
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
Huang C; Xu D; Xia Q; Wang P; Rong C; Su Y
J Pharm Pharmacol; 2012 Dec; 64(12):1741-50. PubMed ID: 23146037
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV suppresses inflammatory mediator production in synoviocytes and collagen‑induced arthritic rats.
Xu H; Wang CY; Zhang HN; Lv CY; Wang YZ
Mol Med Rep; 2016 Apr; 13(4):3289-96. PubMed ID: 26936538
[TBL] [Abstract][Full Text] [Related]
6. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
7. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU].
Tang HH; Zhou M; Liang G
Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV attenuates penicillin-induced epilepsy via inhibiting activation of the MAPK signaling pathway.
Zhu X; Chen Y; Du Y; Wan Q; Xu Y; Wu J
Mol Med Rep; 2018 Jan; 17(1):643-647. PubMed ID: 29115438
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.
Wang M; Huang C; Su Y; Yang C; Xia Q; Xu DJ
J Pharm Pharmacol; 2017 Jun; 69(6):743-752. PubMed ID: 28266023
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MDR1 gene by cepharanthine hydrochloride is related to the activation of c-Jun/JNK in K562/ADR cells.
Han L; Wang Y; Guo X; Zhou Y; Zhang J; Wang N; Jiang J; Ma F; Wang Q
Biomed Res Int; 2014; 2014():164391. PubMed ID: 25386557
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
13. Immune regulation mechanism of Astragaloside IV on RAW264.7 cells through activating the NF-κB/MAPK signaling pathway.
Li Y; Meng T; Hao N; Tao H; Zou S; Li M; Ming P; Ding H; Dong J; Feng S; Li J; Wang X; Wu J
Int Immunopharmacol; 2017 Aug; 49():38-49. PubMed ID: 28550733
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells.
You L; Fang Z; Shen G; Wang Q; He Y; Ye S; Wang L; Hu M; Lin Y; Liu M; Jiang A
Mol Med Rep; 2019 Mar; 19(3):1603-1612. PubMed ID: 30628687
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
[TBL] [Abstract][Full Text] [Related]
16. Cepharanthine hydrochloride reverses P‑glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway.
Huang CZ; Wang YF; Zhang Y; Peng YM; Liu YX; Ma F; Jiang JH; Wang QD
Oncol Rep; 2017 Oct; 38(4):2558-2564. PubMed ID: 28791369
[TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
18. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
19. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
20. Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells.
Ling S; Tian Y; Zhang H; Jia K; Feng T; Sun D; Gao Z; Xu F; Hou Z; Li Y; Wang L
Mol Med Rep; 2014 Dec; 10(6):2891-7. PubMed ID: 25310259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
